1,828
Views
39
CrossRef citations to date
0
Altmetric
Research Article

The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes

, , , , , , , , , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Alyona V. Tiselko, Roman V. Kapustin, Yuliya P. Milyutina, Natalia V. Borovik, Elena I. Abashova & Maria I. Yarmolinskaya. (2022) Glucose variability as the risk factor of preeclampsia in pregnant patients with type 1 diabetes mellitus. The Journal of Maternal-Fetal & Neonatal Medicine 35:25, pages 9639-9646.
Read now
Sümeyra Nergiz Avcıoğlu, Selda Demircan Sezer & Sündüz Özlem Altınkaya. (2022) Circulating s-Endoglin concentrations in non-obese patients with gestational diabetes mellitus. Journal of Obstetrics and Gynaecology 42:5, pages 1126-1131.
Read now
Umit Gorkem, Cihan Togrul & Emine Arslan. (2020) Relationship between elevated serum level of placental growth factor and status of gestational diabetes mellitus. The Journal of Maternal-Fetal & Neonatal Medicine 33:24, pages 4159-4163.
Read now
Angelo Maria Patti, Rosaria Vincenza Giglio, Kalliopi Pafili, Manfredi Rizzo & Nikolaos Papanas. (2019) Advances in pharmacological treatment of type 1 diabetes during pregnancy. Expert Opinion on Pharmacotherapy 20:8, pages 983-989.
Read now
Jalal Poorolajal & Ensiyeh Jenabi. (2016) The association between body mass index and preeclampsia: a meta-analysis. The Journal of Maternal-Fetal & Neonatal Medicine 29:22, pages 3670-3676.
Read now
Tamarra James-Todd, Allison Cohen, Julia Wenger & Florence Brown. (2016) Time-specific placental growth factor (PlGF) across pregnancy and infant birth weight in women with preexisting diabetes. Hypertension in Pregnancy 35:3, pages 436-446.
Read now

Articles from other publishers (33)

Miriam Lopian, Lior Kashani-Ligumsky & Ariel Many. (2023) A Balancing Act: Navigating Hypertensive Disorders of Pregnancy at Very Advanced Maternal Age, from Preconception to Postpartum. Journal of Clinical Medicine 12:14, pages 4701.
Crossref
Roman V. Kapustin, Elizaveta M. Tcybuk, Ekaterina V. Kopteeva, Elena N. Alekseenkova, Sergey V. Chepanov, Elizaveta V. Shelaeva, Olga N. Arzhanova, Andrey V. Korenevsky & Igor Yu. Kogan. (2023) Extended combined screening for preeclampsia prediction in women with diabetes mellitus. Journal of obstetrics and women's diseases 72:2, pages 39-50.
Crossref
Katarzyna Cypryk, Ewa Wender-Ozegowska, Katarzyna Cyganek, Jacek Sieradzki, Kinga Skoczylas, Xiaoxiao Chen, Toni L. Cordero, John Shin & Ohad Cohen. (2023) Insulin pump therapy with and without continuous glucose monitoring in pregnant women with type 1 diabetes: a prospective observational Orchestra Foundation study in Poland. Acta Diabetologica 60:4, pages 553-561.
Crossref
Almudena Lara-Barea, Begoña Sánchez-Lechuga, Manuel Aguilar-Diosdado & Cristina López-Tinoco. (2022) Higher daytime systolic BP, prepregnancy BMI and an elevated sFlt-1/PlGF ratio predict the development of hypertension in normotensive pregnant women. Reproductive Biology and Endocrinology 20:1.
Crossref
Farah Jaffar, Kate Laycock & Mohammed S.B. Huda. (2022) Type 1 Diabetes in Pregnancy: A Review of Complications and Management. Current Diabetes Reviews 18:7.
Crossref
Almudena Lara-Barea, Begoña Sánchez-Lechuga, Antonio Campos-Caro, Juan Antonio Córdoba-Doña, Raquel de la Varga-Martínez, Ana I. Arroba, Fernando Bugatto, Manuel Aguilar-Diosdado & Cristina López-Tinoco. (2022) Angiogenic Imbalance and Inflammatory Biomarkers in the Prediction of Hypertension as Well as Obstetric and Perinatal Complications in Women with Gestational Diabetes Mellitus. Journal of Clinical Medicine 11:6, pages 1514.
Crossref
María M. Pereira, Juan Torrado, Claudio Sosa, Yanina Zócalo & Daniel Bia. (2022) Shedding Light on the Pathophysiology of Preeclampsia-Syndrome in the Era of Cardio-Obstetrics: Role of Inflammation and Endothelial Dysfunction. Current Hypertension Reviews 18:1, pages 17-33.
Crossref
Stefan Verlohren, Shaun P. Brennecke, Alberto Galindo, S. Ananth Karumanchi, Ljiljana B. Mirkovic, Dietmar Schlembach, Holger Stepan, Manu Vatish, Harald Zeisler & Sarosh Rana. (2022) Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia. Pregnancy Hypertension 27, pages 42-50.
Crossref
Sarosh Rana, Suzanne D. Burke & S. Ananth Karumanchi. (2022) Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders. American Journal of Obstetrics and Gynecology 226:2, pages S1019-S1034.
Crossref
Maria Vamvini & Florence M. Brown. 2022. Comprehensive Clinical Approach to Diabetes During Pregnancy. Comprehensive Clinical Approach to Diabetes During Pregnancy 149 188 .
Roman V. Kapustin, Elizaveta M. Tcybuk, Sergey V. Chepanov, Elena N. Alekseenkova, Ekaterina V. Kopteeva & Olga N. Arzhanova. (2021) Evaluation of sFlt-1 and PlGF for predicting preeclampsia in pregnant women with diabetes mellitus. Journal of obstetrics and women's diseases 70:4, pages 43-56.
Crossref
Siehoon Lah, N Wah Cheung, Vincent Lee, Neil Athayde, Emma Inglis & Suja Padmanabhan. (2021) Aspirin and pre‐eclampsia prevention in women with pre‐existing diabetes: a retrospective study. Internal Medicine Journal 51:10, pages 1673-1680.
Crossref
Elizabeth O Buschur & Sarit Polsky. (2021) Type 1 Diabetes: Management in Women From Preconception to Postpartum. The Journal of Clinical Endocrinology & Metabolism 106:4, pages e952-e967.
Crossref
Anna Maria Nuzzo, Domenica Giuffrida, Laura Moretti, Paola Re, Giorgio Grassi, Guido Menato & Alessandro Rolfo. (2021) Placental and maternal sFlt1/PlGF expression in gestational diabetes mellitus. Scientific Reports 11:1.
Crossref
Monica Zen, Suja Padmanabhan, Kewei Zhang, Adrienne Kirby, N. Wah Cheung, Vincent W. Lee & Thushari I. Alahakoon. (2020) Urinary and Serum Angiogenic Markers in Women With Preexisting Diabetes During Pregnancy and Their Role in Preeclampsia Prediction. Diabetes Care 43:1, pages 67-73.
Crossref
A.V. Tisel’ko, M.I. Yarmolinskaya, N.V. Borovik, S.V. Suslova, E.V. Misharina & Yu.P. Milutina. (2020) The functional status of the kidneys in pregnant women with diabetes mellitus (type 1) when using continuous subcutaneous insulin infusion and continuous monitoring of blood glucose levels. Rossiiskii vestnik akushera-ginekologa 20:6, pages 56.
Crossref
Monica Zen, Suja Padmanabhan, Ngai Wah Cheung, Adrienne Kirby, Shilpa Jesudason, Thushari I. Alahakoon & Vincent W. Lee. (2019) Microalbuminuria as an early predictor of preeclampsia in the pre-gestational diabetic population: A prospective cohort study. Pregnancy Hypertension 15, pages 182-188.
Crossref
Kathleen R. Heim, Melissa J. Mulla, Julie A. Potter, Christina S. Han, Seth Guller & Vikki M. Abrahams. (2018) Excess glucose induce trophoblast inflammation and limit cell migration through HMGB1 activation of Toll-Like receptor 4. American Journal of Reproductive Immunology 80:5, pages e13044.
Crossref
Daisy Leon-Martinez, Melissa J. Mulla, Christina S. Han, Lawrence W. Chamley & Vikki M. Abrahams. (2018) Modulation of trophoblast function by concurrent hyperglycemia and antiphospholipid antibodies is in part TLR4-dependent. American Journal of Reproductive Immunology 80:4, pages e13045.
Crossref
I. Cavero-Redondo, V. Martínez-Vizcaíno, A. Soriano-Cano, J.A. Martínez-Hortelano, G. Sanabria-Martínez & C. Álvarez-Bueno. (2018) Glycated haemoglobin A1c as a predictor of preeclampsia in type 1 diabetic pregnant women: A systematic review and meta-analysis. Pregnancy Hypertension 14, pages 49-54.
Crossref
Kathryn J. Gray, Richa Saxena & S. Ananth Karumanchi. (2018) Genetic predisposition to preeclampsia is conferred by fetal DNA variants near FLT1, a gene involved in the regulation of angiogenesis. American Journal of Obstetrics and Gynecology 218:2, pages 211-218.
Crossref
Holger Stepan & Janine Hoffmann. 2018. Preeclampsia. Preeclampsia 175 198 .
Suja Padmanabhan, Vincent W. Lee, Mark Mclean, Neil Athayde, Valeria Lanzarone, Qemer Khoshnow, Michael J. Peek & N. Wah Cheung. (2017) The Association of Falling Insulin Requirements With Maternal Biomarkers and Placental Dysfunction: A Prospective Study of Women With Preexisting Diabetes in Pregnancy. Diabetes Care 40:10, pages 1323-1330.
Crossref
Janine Hoffmann, Victoria Ossada, Marie Weber & Holger Stepan. (2017) An intermediate sFlt-1/PlGF ratio indicates an increased risk for adverse pregnancy outcome. Pregnancy Hypertension 10, pages 165-170.
Crossref
Belinda Jim & S. Ananth Karumanchi. (2017) Preeclampsia: Pathogenesis, Prevention, and Long-Term Complications. Seminars in Nephrology 37:4, pages 386-397.
Crossref
Amy C. Wotherspoon,Ian S. Young,David R. McCance,Valerie A. Holmes,. (2017) Exploring knowledge of pre-eclampsia and views on a potential screening test in women with type 1 diabetes. Midwifery 50, pages 99-105.
Crossref
Frank T. Spradley. (2017) Metabolic abnormalities and obesity’s impact on the risk for developing preeclampsia. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 312:1, pages R5-R12.
Crossref
Anna Z. Feldman & Florence M. Brown. (2016) Management of Type 1 Diabetes in Pregnancy. Current Diabetes Reports 16:8.
Crossref
Beatrice Mosimann, Sophia Amylidi, Lorenz Risch, Ute Wiedemann, Daniel Surbek, Marc Baumann, Christoph Stettler & Luigi Raio. (2016) First-Trimester Placental Growth Factor in Screening for Gestational Diabetes. Fetal Diagnosis and Therapy 39:4, pages 287-291.
Crossref
Paula K. Bautista Niño, Myrte J. Tielemans, Sarah Schalekamp-Timmermans, Jolien Steenweg-de Graaff, Albert Hofman, Henning Tiemeier, Vincent W. Jaddoe, Eric A.P. Steegers, Janine F. Felix & Oscar H. Franco. (2015) Maternal fish consumption, fatty acid levels and angiogenic factors: The Generation R Study. Placenta 36:10, pages 1178-1184.
Crossref
Tracey L. Weissgerber & Lanay M. Mudd. (2015) Preeclampsia and Diabetes. Current Diabetes Reports 15:3.
Crossref
Guadalupe Herrera-Garcia & Stephen Contag. (2014) Maternal Preeclampsia and Risk for Cardiovascular Disease in Offspring. Current Hypertension Reports 16:9.
Crossref
Andrew N. Sharp & Zarko Alfirevic. (2014) First trimester screening can predict adverse pregnancy outcomes. Prenatal Diagnosis, pages n/a-n/a.
Crossref